Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 2,091,698 shares of PODD stock, worth $696 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
2,091,698
Previous 2,135,068
2.03%
Holding current value
$696 Million
Previous $671 Million
3.73%
% of portfolio
0.5%
Previous 0.53%
Shares
8 transactions
Others Institutions Holding PODD
# of Institutions
913Shares Held
60.3MCall Options Held
325KPut Options Held
557K-
Vanguard Group Inc Valley Forge, PA8.8MShares$2.93 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$2.02 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.55MShares$1.51 Billion0.28% of portfolio
-
State Street Corp Boston, MA3.09MShares$1.03 Billion0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.97MShares$654 Million0.04% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $23.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...